HER The TSQ Altis MD Series mass spectrometer offers enhanced sensitivity for demanding quantitative analyses together with speed and robustness. With superb analytical performance, this platform features maximum usability and is powered by Thermo Scientific TraceFinder LDT Software, which provides a workflow-oriented approach to robust, reliable, high-throughput quantitation. The instrument’s ultimate quantitative performance leverages enhanced Thermo Scientific Active Ion Management (AIM+) technology. QR5 segmented hyperbolic-surface quadrupoles deliver best-in-class sensitivity, consistency, and reproducibility, while fast, selected-reaction monitoring enables robust quantitation of more compounds faster. Features include automated compound optimization and intuitive instrument interface as well as optional bi-directional LIS connection available with B-link.
The TSQ Altis MD Series mass spectrometer is intended to identify and quantify inorganic and organic compounds in human specimens for in vitro diagnostic use only by trained, qualified laboratory personnel. It will be used by clinical diagnostic laboratories as a component of a laboratory developed test (LDT) method or workflow.
Read more

Siemens Healthineers recently announced the new RAPIDPoint 500e blood gas system, their latest
solution in critical point-of-care testing. The new system generates blood gas, electrolyte  and metabolyte results used to diagnose and monitor critically ill patients typically in the intensive care unit, operating room or emergency room. The RAPIDPoint 500e blood gas system is available now in all countries requiring the CE mark. Developed with extensive customer feedback, the system is designed to elevate confidence in patient results with Integri-sense technology, streamline workflow with improved simplicity and raise the bar in data security. Cybersecurity is becoming a key operational factor. Health-care providers must protect confidential operator and patient information.
The RAPIDPoint 500e blood gas system incorporates Integri-sense technology, a comprehensive series of automated functional checks designed to deliver accurate test results at the point-of-care. Integri-sense technology combines three levels of automatic quality control (AutomaticQC), multiple calibration routines and advanced software algorithms to generate reliable and clinically actionable test results. It also integrates seamlessly into hospital networks with the Siemens Healthineers Point of Care Ecosystem which offers convenient, remote management of operators and devices located across multiple sites.
Read more

HORIBA UK Ltd, Medical has introduced a new automated digital cell morphology solution in collaboration with CellaVision to help haematology laboratories simplify and expedite the performance of blood and body fluid differentials.
CellaVision’s digital cell morphology systems can now be integrated with HORIBA’s HELO automated haematology platform, enabling unique two-way data flow and rapid validation of cell morphology results. These combined systems automate a number of steps that would otherwise be undertaken manually, thus significantly enhancing laboratory workflows and increasing productivity.
The connectivity and bi-directional information sharing between CellaVision and HORIBA’s haematology systems uniquely support numerous aspects of digital blood cell morphology workflow. These save technician and cytologist time, support ease-of-use, improve flexibility and deliver more accurate results.
Mandy Campbell, Sales and Marketing Manager – Medical, HORIBA UK Ltd, commented, “Slide reading is a mandatory step in laboratories to confirm severe pathology diagnosis. By automating and digitising cell morphology workflow our new joint solution with CellaVision offers significant time saving and results standardisation to enable laboratories to work smarter and perform better.”
CellaVision systems leverage high-speed robotics and digital imaging to automatically locate and capture high-quality images of cells from slides produced by HORIBA’s Yumizen SPS slide maker following automatic slide reflex rules. By automating pre-classification and pre-characterisation of blood cell morphology, this slide digitalisation solution saves time and supports standardisation of slide reading when compared to the use of a traditional microscope for validation of blood smears. In turn, all results and alarms from HORIBA’s haematology analysers can be directly sent to CellaVision.
Data received from HORIBA haematology analysers are used by CellaVision systems in a number of ways to enhance workflows. As all slides are printed with 1D or 2D barcodes by the SPS, automatic distinction of whole blood and body fluids slides are possible without need for specific colour-coded racks when loading.
Furthermore, based on the HORIBA analyser’s WBC value, the CellaVision system will automatically adjust the quantity of pictures it captures to ensure sufficient and representative cell counting. This offers convenience in cases of leucopoenia or aplasia.
A range of CellaVision systems is available to integrate with HORIBA’s HELO haematology platform which can be selected based on a laboratory’s size and throughput. The CellaVision® DM9600 meets the needs of large laboratories with high-volume testing requirements, offering a loading capacity of 96 slides and throughput of 30 slides/hour. For large or small laboratories with lower volume testing needs, the CellaVision® DM1200 and CellaVision® DC-1 offer alternative options.
Read more

The FDA-cleared ChemWell® RPR replaces the manual labor-intensive and subjective visual RPR reading with a fully automatic, 190 results-per-hour process that objectively interprets and stores photographic images. Over the years and around the world many high throughput labs have already given up the advantages of non-treponemal screening, replacing it with more expensive treponemal ELISA testing simply to take advantage of automation. The compromise is no longer necessary.

Automated ChemWell® RPR allows laboratories to use the US CDC recommended traditional nontreponemal screening algorithm instead of the higher-cost and complicated reverse algorithm while reducing hands-on time by 92%, compared to a manual RPR test.

The innovative test system was developed in cooperation with Arlington Scientific Inc. (Salt Lake City, Utah USA) who is selling in North America and Europe under the brand name Evolution. Awareness Technology will supply the rest of the world through its distribution and technical service channels.  

Read more